Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients
AUAUniversity23 Marras 2022

Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients

Appropriate use of Biomarker and Genetic Testing in the Diagnosis and Management of Patients with Prostate Cancer Host: Jay D. Raman, MD, FACS Co-Hosts: Veda Giri, MD and Todd Morgan, MD CME Available: auau.auanet.org/node/37313 At the conclusion of this activity, participants will be able to 1. Assess how to maximize the benefits and minimize the harms of prostate cancer detection by carefully selecting patients and by using the necessary tools to detect clinically meaningful prostate cancer while avoiding unnecessary biopsies and detection of clinically unimportant cancers. 2. Discuss the available blood, urine and tissue biomarkers used to enhance detection of higher-grade prostate cancer, the evidence supporting their use and the clinical scenarios in which they are most valuable to be used. 3. Identify the criteria for genetic testing of prostate cancer patients, the gene panels available, and options for testing these men. 4. Utilize the results of genetic testing to improve outcomes among patients with metastatic prostate cancer, including recommendations regarding PARP-inhibition, chemotherapy and immunotherapy. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Jaksot(425)

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

5 Heinä 201831min

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active...

23 Kesä 20182h 12min

Focal Therapy Interview with John W. Davis, MD, FACS

Focal Therapy Interview with John W. Davis, MD, FACS

Dr. Nitti and Dr. Davis discus the use of focal therapy in the treatment of prostate cancer. @jdhdavis - This file has been updated

15 Kesä 201833min

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

8 Kesä 201842min

Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)

Highlights in Renal Cell Carcinoma: The Roles of the Urologist and Medical Oncologist (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

31 Touko 201841min

AUA2018 074IC - AUA CRPC Guidelines

AUA2018 074IC - AUA CRPC Guidelines

This course will review the 2015 update to the 2013 AUA guidelines on castration-resistant prostate cancer. Faculty will explore the rigorous process used in the development of these evidence-based gu...

23 Touko 20181h 56min

AUA2018 Contemporary Pharmacotherapy for OAB

AUA2018 Contemporary Pharmacotherapy for OAB

The American Urological Association (AUA) recognizes the critical role of the primary care provider in treating patients with urologic conditions. The AUA is pleased to offer this Podcast on one of th...

19 Touko 201859min

Minimally Invasive Treatment Of BPH

Minimally Invasive Treatment Of BPH

Steven A Kaplan, MD joins Dr. Nitti to discuss Minimally Invasive Treatment Of BPH. Dr. Kaplan is Professor of Urology at the Icahn School of Medicine at Mount Sinai and Director of Benign Urologic D...

22 Helmi 201834min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
voi-hyvin-meditaatiot-2
rss-narsisti
psykopodiaa-podcast
adhd-podi
rss-vapaudu-voimaasi
rss-niinku-asia-on
psykologia
rss-duodecim-lehti
rss-valo-minussa-2
aamukahvilla
rss-uskonto-on-tylsaa
kesken
koulu-podcast-2
rss-liian-kuuma-peruna
rahapuhetta
jari-sarasvuo-podcast
filocast-filosofian-perusteet
rss-turun-yliopisto
rss-opi-espanjaa